News from the FDA/CDC
News from the FDA/CDC
New at-home test approved for chlamydia and gonorrhea
“This authorization marks an important public health milestone, giving patients more information about their health from the privacy of their own...
News from the FDA/CDC
U.S. infant mortality rates rise for first time in 2 decades
“We live in a country with significant resources, so the infant mortality rate and the increase are shockingly high.”
News
Test all perinatally exposed infants for HCV: CDC
The CDC noted that rates of HCV infections during pregnancy are on the rise.
News from the FDA/CDC
FDA panel deems phenylephrine ineffective
The committee’s next move is to determine if the drug’s status as Generally Recognized as Safe and Effective should be revoked.
Latest News
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
The cosmetic products include makeup products, nail polishes, shaving creams, other grooming products, perfumes, face and body cleansers, hair...
From the Journals
One in five women report mistreatment during maternity care
Approximately 40% of Black, Hispanic, and multiracial mothers report discrimination.
News from the FDA/CDC
FDA approves first pill for postpartum depression
Zuranolone is a neuroactive steroid that acts on GABAA receptors in the brain responsible for regulating mood, arousal, behavior, and cognition....
News from the FDA/CDC
FDA approves first over-the-counter birth control pill
The product, OPill, is expected to be available early in 2024.
News from the FDA/CDC
FDA panel backs new COVID booster focusing only on variants
Panelists also raised other questions during the meeting, including concerns about moves toward tying COVID vaccinations into the model of annual...
News from the FDA/CDC
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”
News from the FDA/CDC
FDA approves OTC naloxone, but will cost be a barrier?
“The major question is what is it going to cost. In order for people to access it they have to be able to afford it,”